Rhythm Pharmaceuticals Inc — Quarterly Financial Data (NASDAQ:RYTM) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Dividends per share —————— — Dividend yield % —————— — Payout ratio % —————— —

Haberler

Guggenheim raises Rhythm Pharmaceuticals stock price target on guidance

Citizens raises Rhythm Pharmaceuticals stock price target on HO approval outlook

Stifel reiterates Buy on Rhythm Pharmaceuticals stock, $131 target

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Beats Revenue Estimates

Rhythm Pharma Q4 2025 slides: revenue beats as HO launch nears

Rhythm Pharma earnings beat by $0.09, revenue topped estimates

Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: Should You Buy?

Rhythm Pharmaceuticals Could Capture Big Share Of Rare Obesity Market - Rhythm Pharmaceuticals (NASDAQ:RYTM)

RBC Capital initiates Rhythm Pharmaceuticals stock with outperform rating

Ultragenyx (RARE) Reports Q4 Loss, Beats Revenue Estimates

Rhythm Pharmaceuticals at Guggenheim Summit: Expanding Horizons in Biotech

Smith, Rhythm Pharmaceuticals CFO, sells $702k in RYTM stock